Trial Profile
A Single-Centre, Open-label, Parallel-Group, Multiple-Ascending-Dose Study Assessing the Mechanism of Action of Bitopertin (Proof of Mechanism) in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs Bitopertin (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 04 Jan 2018 New trial record